Gadoxetic acid

What is Gadoxetic Acid?

Gadoxetic acid, also known by its brand name Primovist in some regions, is a specialized MRI contrast agent used in diagnostic imaging. It belongs to a class of drugs called paramagnetic contrast media. Unlike general-purpose gadolinium-based contrast agents, Gadoxetic acid possesses unique properties that make it particularly useful for enhancing images of the liver. It helps radiologists visualize and characterize lesions within the liver more effectively, aiding in the diagnosis of various hepatic conditions.

Administered intravenously, Gadoxetic acid temporarily alters the magnetic properties of tissues, allowing for clearer and more detailed images during a Magnetic Resonance Imaging (MRI) scan. Its distinct pharmacokinetic profile, including uptake by hepatocytes, sets it apart for specific liver imaging applications.

How Does it Work?

The primary mechanism of action for Gadoxetic acid revolves around its paramagnetic properties. As a gadolinium-based compound, it contains a gadolinium ion which, when introduced into the body, shortens the T1 relaxation time of protons in tissues. This shortening results in increased signal intensity on T1-weighted MRI sequences, making certain structures appear brighter.

What makes Gadoxetic acid unique is its dual elimination pathway. Approximately 50% of the dose is excreted via the kidneys, similar to other gadolinium agents. However, the other 50% is actively taken up by hepatocytes (liver cells) through organic anion-transporting polypeptide (OATP1B1) transporters, and then excreted into the bile. This hepatobiliary excretion pathway is crucial. It allows the contrast agent to accumulate within healthy liver tissue, enhancing its signal. Lesions that lack functional hepatocytes, such as metastases or certain tumors, will not take up the contrast as efficiently, appearing darker against the brighter, enhanced healthy liver parenchyma. This differential enhancement significantly improves the detection and characterization of focal liver lesions, providing valuable information for clinicians. The agent facilitates better visualization of the hepatobiliary system, including bile ducts.

Medical Uses

The primary medical use of Gadoxetic acid is in diagnostic imaging of the liver. It is specifically indicated for:

• Detection and characterization of focal liver lesions, such as hepatocellular carcinoma (HCC), metastases, adenomas, and focal nodular hyperplasia (FNH).
• Pre-operative assessment of liver lesions, helping surgeons plan interventions.
• Monitoring response to treatment for liver tumors.
• Improving the diagnostic accuracy of MRI in patients with suspected liver disease.

By providing enhanced contrast between healthy liver tissue and diseased areas, Gadoxetic acid aids in differentiating between benign and malignant lesions, which is critical for patient management. It is particularly valuable for its ability to show a "hepatobiliary phase" approximately 20 minutes after injection, where the contrast is concentrated in healthy hepatocytes, making non-enhancing lesions stand out.

Dosage

The administration of Gadoxetic acid is performed by a healthcare professional, typically a radiologist or a trained technician, in a clinical setting. The standard recommended dose for adults is 0.025 mmol/kg body weight, administered as an intravenous bolus injection. This is equivalent to 0.1 mL/kg body weight of the 0.25 mmol/mL solution.

• Administration: The injection is given intravenously over approximately 3-5 minutes, followed by a flush with saline solution to ensure the entire dose reaches the bloodstream.
• Timing: MRI scans are performed immediately after injection for dynamic imaging, and then again after a delay (typically 10-20 minutes for the hepatobiliary phase) to utilize the liver-specific uptake.
• Pediatric Use: The safety and efficacy of Gadoxetic acid in pediatric patients have not been fully established, and its use in this population is generally limited and considered on a case-by-case basis under strict medical supervision.
• Renal Impairment: While Gadoxetic acid has a dual excretion pathway, caution is advised in patients with severe renal impairment. The risk of nephrogenic systemic fibrosis (NSF), although generally lower with macrocyclic agents like Gadoxetic acid, should always be considered.

Always adhere to the specific instructions provided by the prescribing physician and the product's official prescribing information.

Side Effects

Like all medications, Gadoxetic acid can cause side effects, although not everyone experiences them. Most side effects are mild to moderate and transient. Common side effects include:

• Injection Site Reactions: Pain, warmth, or irritation at the injection site.
• Nausea and Vomiting: Often mild and short-lived.
• Headache: A common complaint.
• Dizziness: May occur shortly after administration.
• Taste Disturbance: A metallic or unusual taste in the mouth.
• Urticaria (Hives) or Rash: Mild skin reactions.

Less common but more serious side effects can occur. These include:

• Allergic Reactions (Hypersensitivity): Ranging from mild skin reactions to severe, life-threatening anaphylaxis. Symptoms may include difficulty breathing, severe rash, swelling of the face or throat, and a drop in blood pressure. Medical staff are trained to manage such emergencies.
• Nephrogenic Systemic Fibrosis (NSF): A rare but serious condition associated with gadolinium-based contrast agents, particularly in patients with severe kidney disease. Gadoxetic acid, being a macrocyclic agent, has a lower reported risk of NSF compared to older linear agents, but vigilance is still required, especially in patients with impaired renal function.
• Renal Impairment: Although rare, acute kidney injury has been reported.

Patients should inform their healthcare provider of any pre-existing conditions, allergies, or medications they are taking before receiving Gadoxetic acid.

Drug Interactions

Drug interactions with Gadoxetic acid are generally limited, but it's important to inform your doctor about all medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. The primary concern relates to its unique hepatobiliary uptake and excretion pathway.

• OATP1B1 Inhibitors/Inducers: Medications that inhibit or induce the organic anion-transporting polypeptide 1B1 (OATP1B1) transporter, which is responsible for Gadoxetic acid's uptake into hepatocytes, could potentially alter its pharmacokinetics. Examples of OATP1B1 inhibitors include rifampicin, cyclosporine, and certain protease inhibitors. While significant clinical interactions are not widely reported, caution is advised, and the diagnostic utility might be affected.
• Other Hepatobiliary Agents: Concurrent use with other drugs that are also actively transported into the liver or excreted via the bile might theoretically compete with Gadoxetic acid, though this interaction is generally not considered clinically significant for routine diagnostic procedures.
• Contrast Agents for Other Modalities: Gadoxetic acid is specifically for MRI. It does not interact with contrast agents used for X-ray or CT scans in a way that would cause adverse effects, but care should be taken to ensure the correct agent is used for the intended imaging modality.

Always consult your healthcare provider or pharmacist for a comprehensive list of potential interactions.

FAQ

Is Gadoxetic acid safe for everyone?

While generally safe, it's not suitable for everyone. Patients with severe kidney disease, a history of allergic reactions to contrast agents, or certain other medical conditions may not be candidates. Your doctor will assess your medical history.

How is Gadoxetic acid administered?

It is administered as a single injection into a vein, typically in the arm, by a healthcare professional.

What should I expect during an MRI with Gadoxetic acid?

You will lie on a table that slides into the MRI scanner. The injection will be given, and imaging will occur immediately and again after a short delay (e.g., 10-20 minutes) to capture the hepatobiliary phase. You may feel a cool sensation during the injection or a metallic taste.

Can Gadoxetic acid cause long-term side effects?

The most significant long-term concern is Nephrogenic Systemic Fibrosis (NSF), primarily in patients with severe kidney impairment. However, Gadoxetic acid is a macrocyclic agent with a lower reported risk compared to older linear agents. Your doctor will assess your kidney function before administration.

Are there alternatives to Gadoxetic acid for liver MRI?

Yes, other gadolinium-based contrast agents can be used for general MRI enhancement, but they lack the specific hepatobiliary uptake of Gadoxetic acid, making them less effective for detailed liver lesion characterization. Non-contrast MRI may also be an option for certain conditions.

Products containing Gadoxetic acid are available through trusted online pharmacies. You can browse Gadoxetic acid-based medications at ShipperVIP or Medicenter.

Summary

Gadoxetic acid is a specialized and highly effective diagnostic imaging agent used in Magnetic Resonance Imaging (MRI) of the liver. Its unique dual elimination pathway, including active uptake by hepatocytes, allows for superior detection and characterization of focal liver lesions, significantly aiding in the diagnosis and management of various hepatic conditions. While generally well-tolerated, it's crucial to be aware of potential side effects, particularly allergic reactions and the rare risk of Nephrogenic Systemic Fibrosis (NSF) in susceptible individuals. Always discuss your full medical history with your healthcare provider before receiving Gadoxetic acid to ensure its safe and appropriate use for your specific diagnostic needs.